Clinical Anesthesia Procedures
Specific Considerations with Cardiac Disease - Hypertrophic cardiomyopathy
To view the entire topic, please log in or purchase a subscription.
Anesthesia Central is an all-in-one web and mobile solution for treating patients before, during, and after surgery. This collection of drugs, procedures, and test information is derived from Davis’s Drug, MGH Clinical Anesthesia Procedures, Pocket Guide to Diagnostic Tests, and PRIME Journals. Explore these free sample topics:
-- The first section of this topic is shown below --
Hypertrophic cardiomyopathy is a cardiac disorder characterized by asymmetric LV hypertrophy and impaired relaxation in diastole. Although most patients with hypertrophic cardiomyopathy do not have an increased LV outflow tract gradient at rest, many of them develop dynamic outflow tract obstruction with decreased filling and increased contractility. Under these conditions, as flow accelerates through the narrowed LV outflow tract, it creates drag, which pulls the anterior leaflet of the mitral valve toward the septum. This systolic anterior motion (SAM) of the anterior mitral leaflet leads to further outflow obstruction and mitral regurgitation.
-- To view the remaining sections of this topic, please log in or purchase a subscription --
Hypertrophic cardiomyopathy is a cardiac disorder characterized by asymmetric LV hypertrophy and impaired relaxation in diastole. Although most patients with hypertrophic cardiomyopathy do not have an increased LV outflow tract gradient at rest, many of them develop dynamic outflow tract obstruction with decreased filling and increased contractility. Under these conditions, as flow accelerates through the narrowed LV outflow tract, it creates drag, which pulls the anterior leaflet of the mitral valve toward the septum. This systolic anterior motion (SAM) of the anterior mitral leaflet leads to further outflow obstruction and mitral regurgitation.
There's more to see -- the rest of this topic is available only to subscribers.
